Health & Biotech
Orthocell’s collagen-membrane dental-regeneration product Striate+ debuts in Canada
Recce’s reconnaissance against superbug – infiltrate, eliminate, escape undetected
Long Shortz: Race Oncology’s boardroom renewal
Twiggy’s Tenmile to become largest shareholder of Lumos Diagnostics
Alive and Kicking: Watch this space on controversy-free stem-cell therapy trials, says Cynata
Bio Curious: How Dimerix negotiates the ‘valleys of death’ on the winding road to drug approval
Here’s cheers – Calmer Co capitalises on Kava trend
Alive and Kicking: Lumos Diagnostics attracts ‘Twiggy’ Forrest as cornerstone holder in $10m raise
August Health Winners: LTR Pharma, Control Bionics lead sector at the ‘cusp of an extraordinary era’
Alive and Kicking: Noxopharm has difficult brain cancer in its sights
ASX Health Stocks: Imugene reveals promise in lymphoma trial, stock soars 27pc
Dr Boreham’s Crucible: Diverse ASX biotech gun Telix brushes off suggestions it’s peaked
ScoPo’s Powerplays: ASX health stocks flat in ‘ocean with no breeze’
Neurotech chases another orphan drug designation
‘Significant milestone’ – EBR submits final PMA module to FDA
TrivarX’s AI is screening for depression by monitoring sleep
ASX Health Stocks: Clinuvel, MedAdvisor rally after hitting high notes on profits
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
